Clinical trial · Observational
Anatomical Location and Metastasis Pattern of Intrapulmonary Lymph Nodes in NSCLC (ECTOP-1010)
Anatomical Location and Metastasis Pattern of Intrapulmonary Lymph Nodes in Non-small Cell Lung Cancer: a Multi-center, Prospective Observational Clinical Trial
NCT05094882CI-TRIAL-00068108unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a clinical trial from Eastern Cooperative Thoracic Oncology Project (ECTOP), numbered as ECTOP-1010. Anatomical Location and Metastasis Pattern of Intrapulmonary Lymph Nodes (Group 11-13) in Non-small Cell Lung Cancer: a Multi-center, Prospective observational Clinical Trial
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Carcinoma | Carcinoma | ONTOLOGY_EXACT | 0.98 |
| Non-small Cell Lung Cancer | Lung Non-Small Cell Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| pulmonary lobectomy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (5)
- label
- RUL
- description
- patients who recieved the resection of right upper lobe (RUL)
- interventionNames
- Procedure: pulmonary lobectomy
- label
- RML
- description
- patients who recieved the resection of right middle lobe ()
- interventionNames
- Procedure: pulmonary lobectomy
- label
- RLL
- description
- patients who recieved the resection of right lower lobe (RML)
- interventionNames
- Procedure: pulmonary lobectomy
- label
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: 1. Preoperative examination showed patients with clinical T1 peripheral non-small cell lung cancer (NSCLC); 2. The lesion is located in a single lung segment or between two adjacent lung segments; 3. Perform radical lobectomy; 4. The preoperative examination did not reveal unresectable lymph nodes; 5. Have not received any other tumor-related treatments (including chemotherapy, radiotherapy, targeted therapy, immunotherapy, etc.) before surgery; 6. No malignant tumor history; 7. No contraindications to surgery (ECOG score 0-1 points); Exclusion Criteria: 1. Pathology revealed patients with non-T1 stage non-small cell lung cancer (NSCLC); 2. Radical lobectomy is not performed; 3. Acception of any anti-tumor treatment before surgery (excluding Chinese medicine treatment); 4. Refused to enter the group or asked to leave the group.
References
Publications (0)
Data not yet available
No reference posted for this study.